Regeneron Exceeds Q4 Expectations, Announces Dividend and Buyback Program
Regeneron beat Q4 expectations with strong Dupixent sales and a 2% rise in Eylea revenue. The company also announced a new dividend and a $3 billion share buyback program.
Regeneron Exceeds Q4 Expectations, Announces Dividend and Buyback Program Read More »